Payments Accepted with PayPal

  Liv.52 Tablets
(Regular Strength)

The original Liv.52 tablets.

  Liv.52 Tablets
(Double Strength)

As the original Liv.52 tablets, but double strength.

  Liv.52 Syrup
Easy to take Liv.52 syrup, popular with the elderly.

  Liv.52 HB
For the treatment of Hepatitis B.

  Liv.52 Vet
Liv.52 Drops and syrup for Cats, Dogs, Kittens and Puppies.

Specially formulated for alcoholic liver diseases.

The only hepatoprotector with the L factor.

  Party Smart
Prevent hangovers, protect the liver whist drinking alcohol.

Liver, Kidney and Blood detox.

PURE HERB - Cleansing of Organs, Colon, Digestion, Blood Purifier and Rejuvenates.

  Home Liver Test Kit
Test your liver condition in the privacy of your own home.

  Home Family Health Screening Test Kit
Test your Liver, Kidney, Heart and Urinary Tract condition in the privacy of your own home.

  ** Discount Packages **
Discounted Product Combinations!

  Liv 52 Ingredients

  Liv 52 Research

  Liv 52 Benefits

  Liv 52 Liver Facts

  Liv 52 Vs. Milk Thistle

  Liv 52 for Anabolic Steroids

More Liv-52 Research Studies and Clinical Trials

Hepatoprotective effects of Liv-52 on ethanol induced liver damage in rats: Liv-52 treatment was found to have protective effects on the activity of superoxide dismutase and the levels of glutathione. The results obtained from the study indicate hepatoprotective nature of Liv-52 which might be attributed to its ability to inhibit lipid peroxidation.

The effect of the heptoprotective agent LIV 52 on liver damage: Administration of LIV 52 can improve the subjective condition and clinical parameters in patients with liver damage, in particular in alcoholic liver damage and in steatosis.

Hepatoprotective effect of Liv-52 and kumaryasava on carbon tetrachloride induced hepatic damage in rats Results indicate that Liv-52 and kumaryasava have protective effect on hepatic enzyme induced due to CCl4 hepatotoxicity.

Effect of Liv.52, a herbal preparation, on absorption and metabolism of ethanol in humans Liv.52 enhanced the rate of absorption of ethanol and rapidly reduced acetaldehyde levels, which may explain its hepatoprotective effect on ethanol-induced liver damage.

Prevention of mercuric chloride induced histopathological changes in the small intestine of mice with LIV-52 Again, use of drug appeared useful. At least under laboratory conditions this herbal drug seems to reduce Hg-induced pathological changes in small intestine of mice.

Chemopreventive action of Liv. 52 on DMBA-induced papillomagenesis in skin of mice The cumulative number of papillomas was also reduced to 16 and 19 in animals treated with Liv. 52 at peri-initiational and post-initiational stages, respectively.

Miscellaneous research studies and clinical trials on efficacy of Liv-52

  1. Effect of Liv.52 in digestive disorders among children (pdf)
    Khrushcheva, N.A. and Safronova, L.E., State Medical Academy based in Ural, Regional Children's Clinical Hospital, Ekaterinburg, Russia, Capsule (2002): (XLI), 4, January / March.

  2. Use of hepatoprotective agents in hepatomegaly syndrome in children: An experience with Liv.52 Syrup (pdf)
    Otilia Marginean, MD, PhD, Ioana Micle, MD, PhD, Maria Lesovici, MD, PhD, Pediatric Hospital "Louis Turcanu", Timisoara, Romania, Raluca Balean, MD, Budiu Ioana, MD, County Hospital Nr. 1, Timisoara, Romania, and Edited by: Kala Suhas Kulkarni, MD, MCPS Medical Advisor, R&D Center, The Himalaya Drug Company, Bangalore, Karnataka, India, Medicine Update (2002): (10), 8, 57.

  3. Physiological Icterus of the newborn and the role of Liv.52 (pdf)
    Goel, S.P., Lecturer, Department of Pediatrics, Garg, B.K., Professor and Head of the Department of Pediatrics Sharma, D.K., Professor in the Department of Pediatrics, Upadhyay, V.K., Lecturer in the Department of Pediatrics, L.L.R.M. Medical College, Meerut, India, Probe (1994): (XXXIV), 1, 45.

  4. Prevention of mercuric chloride-induced histopathological changes in the small intestine of mice with Liv.52 (pdf)
    Johnson, V. and Rathore, H.S., Cell Biology Unit, School of Studies in Zoology, Vikram University, Ujjain, Madhya Pradesh, Indian Journal of Medical Sciences (1994): (48), 11, 253.

  5. Chemopreventive action of Liv.52 on DMBA-induced papillomagenesis in skin of mice (pdf)
    Ritu Prashar and Ashok Kumar, Department of Zoology, University of Rajasthan, Jaipur, Rajasthan, Indian Journal of Experimental Biology (1994): (32), Sep., 643.

  6. Evaluation of the role of Liv.52 treatment in swiss albino mice during pre- and post-natal development (pdf)
    Saini, M.R., Sharma, K. and Kumar, A., Radiation Biology Laboratory, University of Rajasthan, Jaipur, India, Probe (1994): (XXXIII), 4, 343.

  7. Cytogenetic effects of Liv.52 on the male germline cells of poekilocerus pictus (Acrididae: Orthoptera) (pdf)
    Edward Gururaj, M. and Uma, O., Department of Studies in Zoology, University of Mysore, Mysore, Karnataka, Journal of Mysore University (1993): (33), 181.

  8. Role of Liv.52 and Geriforte as general metabolic tonics in drug addicts (pdf)
    Jain, N.C., Government Rajindera Medical College and Hospital, Patiala, Singal, R.P., Dayanand Hospital, Ludhiana, Punjab, and Shahi, S.R., S.S.M.D. Ayurvedic College and Hospital, Moga, Punjab, Probe (1992): (XXXII), 1, 32.

  9. Absence of teratogenic effect of Liv.52 in albino rats (pdf)
    Singh, N., Verma, P. and Mishra, N., Upgraded Department of Pharmacology and Therapeutics, K.G. Medical College, Lucknow, Uttar Pradesh, Journal of Biological and Chemical Research (1990): (9), 445.

  10. Inhibition of clastogenic effect of radiation by Liv.52 in the bone marrow of mice (pdf)
    Ganesh Chandra Jagetia and Ganapathi, N.G., Department of Radiobiology, Kasturba Medical College, Manipal, Karnataka, Mutation Research (1989): (224), 4, 507.

  11. Lack of teratogenicity of Liv.52 (pdf)
    Chauhan, B.L., Gurjar, P.A. and Kulkarni, R.D., R&D Centre, The Himalaya Drug Co., Bombay, Maharashtra, Probe (1988): (XXVIII), 1, 36.

  12. Liv.52 protection against radiation-induced abnormalities on mammalian prenatal development (pdf)
    Saini, M.R., Kumar, S., Department of Zoology, University of Rajasthan, Jaipur, Rajasthan, and Saini, N., Department of Paediatrics, E.S.I. Hospital, Jaipur, Rajasthan, Radiobiology and Radiotherapy (1985): (26), 3, 385.

  13. The treatment of non-suppurative hepatic amoebiasis with Liv.52 as an adjuvant to antiamoebic drugs (pdf)
    Bose, S.L. and Rout, A.K., Department of Medicine, S.C.B. Medical College, Cuttack, Orissa, Indian Medical Journal (1983): 1, 3.

  14. Role of Liv.52 in the treatment of pityriasis alba (pdf)
    Chakraborty, A.K., G.T. Road, Kalitala, Serampore, West Bengal, Capsule (1983): 1, 9.

  15. Liv.52 in burns cases (pdf)
    Malla, C.N. and Surinder Singh, Medical College and H.M.H.S. Hospital, Srinagar, Jammu and Kashmir, Probe (1982): (XXII), 1, 24.

  16. Clinical trial of Liv.52 in burns (pdf)
    Parangusa Das, R.A., Vijayalakshmi, B. and Subhashini, M.,Victoria Hospital, Bangalore, Karnataka, Probe (1982): (XXI), 3, 192.

  17. Role of Liv.52 in psychiatric illness (pdf)
    Rustom N. Burjorjee, Calcutta Medical Centre, London Street, Calcutta, West Bengal, Capsule (1982): 5, 98.

  18. A case study on Liv.52 an adjuvant in diabetes mellitus (pdf)
    Sinha, A.K., P.T.P.S. Hospital, Patralu, District, Hazaribagh, Bihar, Capsule (1982): 8, 178.

  19. Effect of Liv.52 on liver lipids (pdf)
    Alok Saxena, Sharma, S.K. and Garg, N.K., Department of Biochemistry, Central Drug Research Institute, Lucknow, Uttar Pradesh, Indian Journal of Experimental Biology (1980): 11, 1330.

  20. Potentiation of barbiturate hypnosis in rats by Liv.52 (pdf)
    Dhume, V.G., Goa Medical College, Panaji, Goa, and Bijlani, C.J., T.N. Medical College, Bombay, Maharashtra, The Clinician (1979): (43), 2, 59.

  21. Evaluation of Liv.52 in the treatment of jaundice with pregnancy (pdf)
    Arun Kumar Mitra and Abhik De, Calcutta Medical College, West Bengal, Probe (1978): (XVII), 2, 143.

  22. Liv.52 in herpes-progenitalis (pdf)
    Iswar Tanwani, Howrah Road, Deolali Cantonment, Nasik District, Maharashtra, Journal of National Integrated Medical Association (1976): (18), 3, 98.

  23. Effect of Liv.52 on serum lipids in normal and patients suffering from ischaemic heart disease (pdf)
    Rao, C.R. and Subba Rao, A., Bowring and Lady Curzon Hospital, Postgraduate and Research Institute, Bangalore, Karnataka, Probe (1975): (XIV), 3, 177.

  24. Radioactive Rose Bengal test of liver function – A preliminary report of Liv.52 trial (pdf)
    Rajagopal, K.R., Radio-Isotope Department, Barnard Institute of Radiology, Government General Hospital, Madras, Tamil Nadu, Probe (1974): (XIV), 1, 50.

  25. A clinical study of the therapeutic efficacy of Liv.52 as an adjuvant in the treatment of hepatic amoebiasis (pdf)
    Sethi, J.P. and Suresh Meratwal, Department of Medicine, S.M.S. Medical College and Attached Hospital, Jaipur, Rajasthan, Probe (1973): (XII), 3, 129.

  26. Gastrointestinal allergy treated with Liv.52 – A case report (pdf)
    Tripathi, A.R., Department of Forensic Medicine, Institute of Medical Services, Banaras Hindu University, Varanasi, Uttar Pradesh, Capsule (1973): June/July, 30.

  27. Liv.52 in dermatology (pdf)
    Behl, P.N., Skin Institute, Delhi, Probe (1972): (XI), 2, 100.

  28. Therapy of toxaemias of pregnancy (pdf)
    Narone, J.N., and Raj Narone (Mrs.), Department of Gynaecology and Obstetrics, Patna Medical College, Patna, Bihar, Probe (1972): (XI), 2, 120.

  29. Some studies on physiological jaundice of the new-born (pdf)
    Srivastava, J.R., Bhalla, J.N. and Arora, A., G.S.V.M. Medical College, Kanpur, Uttar Pradesh, Probe (1972): (XII), 1, 4.

  30. Liv.52 in vitiligo (pdf)
    Punshi, S.K. Consultant Dermatologist and Abroal, S.K., Amravati, M.S., Probe (1970): (X), 1, 12.

  31. Studies with Liv.52 (pdf)
    Lala Surajnandan Prasad, Department of Paediatrics, Patna University, Patna, Bihar and Devendra Tripathy, Hospital for Children, Patna Medical College Hospital, Patna, Bihar, Probe (1969): (IX), 1, 1.

  32. Metabolic effect of an indigenous compound on sportsmen (pdf)
    Mathur, D.N., The National Institute of Sports, Patiala, Punjab, Probe (1969): (VIII), 4, 144.

  33. Liv.52 in general practice (pdf)
    Shah, N.B., Malegaon City, Nasik, Maharashtra, Probe (1969): (VIII), 3, 101.

  34. A clinical study – Physiological jaundice in neonates (pdf)
    Chafekar, V.D., Annapoornabai Maternity and Nursing Home, Gadag, Karnataka, Probe (1968): (VII), 3, 85.

  35. Observations on Liv.52 (pdf)
    Patrao, S., B.Y.L. Nair Hospital and T.N. Medical College, Bombay, Maharashtra, Journal of Indian Medical Profession (1957): 8, 1878.

  36. Ascitis due to liver deficiency treated with an indigenous drug (pdf)
    Sule, C.R., Sathe, P.M., Koshy, M.C. and Desphande, M.S., The Indian Practitioner (1956): (IX), 4, 357.